DOI:
10.1055/s-00000071
Seminars in Neurology
LinksClose Window
References
Kappos L, Wiendl H, Selmaj K , et al.
Daclizumab HYP versus interferon beta-1a in relapsing multiple sclerosis.
N Engl J Med 2015;
373 (15) 1418-1428
We do not assume any responsibility for the contents of the web pages of other providers.